LOS ANGELES, Dec. 10, 2018 (GLOBE NEWSWIRE) -- The global connected drug delivery devices market size is expected to be around USD 718.9 billion by 2026, the market is projected to grow with 26.1% CAGR during the forecast timeframe. Supportive government regulation to encourage the adoption of advance healthcare infrastructure is expected to bolster the global connected drug delivery devices market growth.
DOWNLOAD SAMPLE PAGES@ https://www.acumenresearchandconsulting.com/request-sample/910
Augmented patient engagement and connectivity due to growing penetration of Internet of Things (IoT) is anticipated to boost the global connected drug delivery devices market over the forecast timeframe. Non-adherence to prescribed medications is a substantial parameter for augmented disease burden and healthcare costs. The effect of non-adherence can comprise of suboptimal patient outcomes reduced drug sale, and lower product consumption. These connected systems are used for improvising the patient adherence towards prescribed medications by doctor of medicine.
These connected drug delivery devices aid physicians in observing patient compliance to prescribed therapy and alter patient treatment as per the need to the patient. Growing number of initiatives spreading awareness regarding about the complications caused by over or under dosing of medicines are anticipated to encourage the acceptance of connected drug delivery devices during the forecast period.
VIEW DETAIL REPORT@ https://www.acumenresearchandconsulting.com/connected-drug-delivery-devices-market
Therefore, growing awareness about the adversarial effects of non-adherence is expected to increase the connected drug delivery devices market growth. Awareness regarding the advantages of connected systems over conventional systems is also projected to boost the demand for the connected drug delivery devices, thus positively impact the growth of the market over the coming years.
The global connected drug delivery devices market is bifurcated into four major segments named end-user, product, technology, and region. On the basis of the end-user the global connected drug delivery devices market is segmented into homecare centers and healthcare providers. On the basis of product the connected drug delivery devices market is segmented into integrated connected devices and connected sensors. These connected sensors are further bifurcated into inhaler sensors and injection sensors, and the integrated connected devices is also further segmented into integrated inhaler, and integrated injection. On the basis of technology, the connected drug delivery devices market is segmented into Bluetooth, NFC, other technologies (cellular, low power wide area network). On the basis of region the global connected drug delivery devices market is segmented into Asia Pacific, North America, Latin America Europe, and Middle East & Africa.
The sensors segment accounted for 72.6% of the global revenue share in 2017 and is expected to witness lucrative growth over the forecast period. Connected sensors are add-on devices that can be fitted over conventional drug delivery devices. These sensors are further classified into inhaler sensors and injection sensors.
Connected sensors are very economics than integrated systems. These devices can be easily fitted or fixed on the present devices and consequently, decrease in the switching cost from an already existing drug delivery device to an integrated one that are more expensive. Therefore, acceptance of these sensors in cost-sensitive economies is anticipated to be faster, which is expected to drive market revenue.
Integrated connected systems are expected to showcase the fastest growth with a CAGR of 29.2% in the coming years. Integrated connected systems comprise of number of sensors encased in a single device. These devices are complex as compared to the sensors and provide more valuable insights to about the patient’s healthcare, as well as healthcare and its service providers. They deliver numerous added benefits over connected sensors, for instance, advanced sensing options.
Integrated systems are more expensive due to a number of complex functions. Though, with growing demand and entry of new businesses in this space, the manufacturing cost is anticipated to reduce. This parameter is also anticipated to assist the growth of the conventional drug delivery devices market.
The key players catering to the global connected drug delivery devices market are Proteus Digital Health, Merck, Adherium, Propeller Health, and BIOCORP. These players are investing huge capital to innovate the product portfolio as the competition in the market is increasing with rapid pace. Also, with changing technology the need for better healthcare infrastructures are increasing, so cater the need of the customers, players are continuously innovating new products.
Inquiry Before Buying@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/910
TABLE OF CONTENT
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Connected Drug Delivery Devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Connected Drug Delivery Devices Market By Product
1.2.2.1. Global Connected Drug Delivery Devices Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Connected Drug Delivery Devices Market Revenue Share By Product in 2017
1.2.2.3. Connected Sensors
1.2.2.4. Integrated Connected Devices
1.2.2.5. Others
1.2.3. Connected Drug Delivery Devices Market By Technology
1.2.3.1. Global Connected Drug Delivery Devices Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Bluetooth
1.2.3.3. NFC
1.2.3.4. Other Technologies
1.2.4. Connected Drug Delivery Devices Market By End Users
1.2.4.1. Global Connected Drug Delivery Devices Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Healthcare Providers
1.2.4.3. Homecare Centers
1.2.4.4. Others
1.2.5. Connected Drug Delivery Devices Market by Geography
1.2.5.1. Global Connected Drug Delivery Devices Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Connected Drug Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Connected Drug Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Connected Drug Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Connected Drug Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Connected Drug Delivery Devices Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Homecare Centers Production Date of Global Connected Drug Delivery Devices Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Connected Drug Delivery Devices Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Connected Drug Delivery Devices Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Connected Drug Delivery Devices Major Manufacturers in 2017
CHAPTER 4. CONNECTED DRUG DELIVERY DEVICES MARKET BY PRODUCT
4.1. Global Connected Drug Delivery Devices Revenue By Product
4.2. Connected Sensors
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Integrated Connected Devices
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Other
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. CONNECTED DRUG DELIVERY DEVICES MARKET BY TECHNOLOGY
5.1. Global Connected Drug Delivery Devices Revenue By Technology
5.2. Bluetooth
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. NFC
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Other Technologies
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. CONNECTED DRUG DELIVERY DEVICES MARKET BY END USERS
6.1. Global Connected Drug Delivery Devices Revenue By End Users
6.2. Healthcare Providers
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Homecare Centers
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Others
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 7. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET BY COUNTRY
7.1. North America Connected Drug Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Connected Drug Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Connected Drug Delivery Devices Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
CHAPTER 8. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET BY COUNTRY
8.1. Europe Connected Drug Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Connected Drug Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
CHAPTER 9. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET BY COUNTRY
9.1. Asia-Pacific Connected Drug Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Connected Drug Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
CHAPTER 10. LATIN AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET BY COUNTRY
10.1. Latin America Connected Drug Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Connected Drug Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
CHAPTER 11. MIDDLE EAST CONNECTED DRUG DELIVERY DEVICES MARKET BY COUNTRY
11.1. Middle East Connected Drug Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Connected Drug Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
CHAPTER 12. AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET BY COUNTRY
12.1. Africa Connected Drug Delivery Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Connected Drug Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
CHAPTER 13. COMPANY PROFILE
13.1. Proteus Digital Health
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Propeller Health
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Merck
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Adherium
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. BIOCORP
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Others
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/910
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
Follow Us:
https://www.facebook.com/acumenresearchandconsulting
https://www.linkedin.com/company/acumen-research-and-consulting/
Browse More Press Releases: http://trendsdesk.com/